Faes Farma

Faes Farma Interest Coverage

The Interest Coverage Ratio of Faes Farma (FAE.MC) as of Sep 30, 2026 is 139.25. In the previous year, Interest Coverage Ratio was 123.24 — a change of 12.99% (higher).

Interest Coverage

139.25

YoY

12.99%

Last updated:

Interest Coverage Ratio of Faes Farma is 2026 139.25 . Interest Coverage Ratio of Faes Farma was 2025 123.24 . It decreases by 12.99% higher compared to the previous year.

The Faes Farma Interest Coverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Interest Coverage
Date
Interest Coverage
Jan 1, 2017
39.04 EUR
Jan 1, 2018
194.99 EUR
Jan 1, 2019
106.07 EUR
Jan 1, 2020
41.78 EUR
Jan 1, 2021
299.94 EUR
Jan 1, 2022
1,279.90 EUR
Jan 1, 2023
123.24 EUR
Jan 1, 2024
139.25 EUR
The Faes Farma Interest Coverage history
YEARInterest CoverageYoY
139.25+12.99%
123.24-90.37%
1,279.90+326.72%
299.94+617.95%
41.78-60.61%
106.07-45.60%
194.99+399.48%
39.04-75.18%
157.32+95.88%
80.31+55.38%
51.69—
Access this data via the Eulerpool API

Faes Farma Stock analysis

What does Faes Farma do? The history of Faes Farma SA dates back to 1933, when the company was founded in Barcelona, Spain. The founders had a vision to develop innovative products that would contribute to improving the health and well-being of people. Over the following decades, the company grew continuously and established itself as one of the leading players in the pharmaceutical industry. The business model of Faes Farma SA is focused on the development and marketing of products for the healthcare industry. The company relies on research and development to develop innovative solutions for various therapeutic areas. Faes Farma SA distributes its products worldwide through a network of partners and distributors, with a focus on Europe and Latin America. Faes Farma SA operates in three different divisions. The first division is pharmaceuticals, where the company offers products for various areas such as respiratory diseases, allergies, pain, and inflammation. An important part of this segment is the product Bilastine, which is used for the treatment of allergies and is considered an alternative to antihistamines. The second division is animal health. Here, Faes Farma SA offers products for the treatment of pets, including preparations against fleas, ticks, and worms. One of the most well-known products in this area is the Stangest brand, which is considered the leading brand for animal health in Spain. The third division of Faes Farma SA is the business of medical devices and diagnostics. Here, the company offers a wide range of products for various medical applications, including devices for monitoring vital signs and diagnostics for infectious diseases. Overall, Faes Farma SA is a company with a diversified product portfolio that is of interest to both end consumers and healthcare professionals and pet owners. The company has continuously developed and invested in research and development in recent years to expand its product offering and provide innovative solutions for various medical needs. Faes Farma SA is a company that stands out for its commitment to the development of innovative products and its dedication to the health and well-being of humans and animals. With a strong focus on research and development and a wide distribution network, the company has solidified its position in the pharmaceutical industry and will continue to play an important role in the market. Faes Farma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Faes Farma stock

Interest Coverage Ratio of Faes Farma is 139.25 in 2026.

Interest Coverage Ratio of Faes Farma changed from 123.24 to 139.25, representing a 12.99% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Interest Coverage Ratio Faes Farma since 2006 – with annual values, charts, and detailed analysis.

The Interest Coverage ratio measures a company's ability to pay interest on its debt. Higher ratios indicate greater financial strength and lower default risk.

Interest Coverage = EBIT / Interest Expense

A 'good' varies by industry and company stage. On Eulerpool, you can compare Interest Coverage Ratio's Faes Farma with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Faes Farma

All Key Metrics — Faes Farma